Kevin Weil Launches Warp Sciences to Automate Drug Discovery Labs with Robotics
Kevin Weil, the former science lead at OpenAI, has founded Warp Sciences, an AI startup dedicated to automating laboratory tasks for drug discovery. The company has successfully raised $215 million at a valuation of $865 million, as announced by Weil on X. This funding round was led by Lightspeed, w...